Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ – straight from the corporate horse’s mouth

Here you have it from the horse’s own mouth so to speak. This explains why the cure for cancer is so elusive & why the natural remedies folk have tried that really work are suppressed, whilst chemo for instance has a minuscule 4% success rate.  EWR

From cnbc.com

“While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.”

Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering “gene therapy” treatment: cures could be bad for business in the long run.

“Is curing patients a sustainable business model?” analysts ask in an April 10 report entitled “The Genome Revolution.”

“The potential to deliver ‘one shot cures’ is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies,” analyst Salveen Richter wrote in the note to clients Tuesday. “While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.”

READ MORE

 

https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html?fbclid=IwAR18i-ofXnIdsxxi2Qec8vp8p3gWVE2FCqUehqOBAGQ0BjziaZCONCwcrR8

Image by Michal Jarmoluk from Pixabay

6 thoughts on “Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ – straight from the corporate horse’s mouth”

  1. When I wrote The Target List novel earlier this year, I was called an antivaxxer and accused of being anti medicine by some reviewers. The story’s underlying premise is that the pharmaceutical industry would rather destroy a lifesaving technology that could cure cancer without drugs, than allow it to flourish and help healthcare consumers worldwide.

    How can people believe that drug companies profiting from certain diseases (intellectual properties) would pay for research that would lead to the eradication of said diseases? When a company makes a fortune on a specific disease, it’s not going to try and eliminate that cash cow. This is common business sense!

    Liked by 1 person

  2. Telling people that cancer charity money goes to drug companies is often a waste of time. I have to admit there was a time when I would not have believed that anyone let alone medics could be so callous. I know better now through personal experience.
    I was watching something that confirmed what you are saying about the percentage of success with chemotherapy. He was also saying that many cancer patients cure themselves and that the chemo kills those who would otherwise recover naturally.
    Off topic: Insect DNA in vaccines? That’s a new one on me, any info?

    Liked by 1 person

Comments are closed.